全文获取类型
收费全文 | 440篇 |
免费 | 62篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 10篇 |
妇产科学 | 2篇 |
基础医学 | 28篇 |
口腔科学 | 3篇 |
临床医学 | 28篇 |
内科学 | 34篇 |
皮肤病学 | 80篇 |
神经病学 | 1篇 |
特种医学 | 2篇 |
外科学 | 10篇 |
综合类 | 41篇 |
预防医学 | 3篇 |
眼科学 | 5篇 |
药学 | 140篇 |
中国医学 | 13篇 |
肿瘤学 | 110篇 |
出版年
2024年 | 2篇 |
2023年 | 6篇 |
2022年 | 5篇 |
2021年 | 6篇 |
2020年 | 8篇 |
2019年 | 10篇 |
2018年 | 14篇 |
2017年 | 15篇 |
2016年 | 10篇 |
2015年 | 21篇 |
2014年 | 18篇 |
2013年 | 35篇 |
2012年 | 13篇 |
2011年 | 25篇 |
2010年 | 14篇 |
2009年 | 28篇 |
2008年 | 24篇 |
2007年 | 23篇 |
2006年 | 36篇 |
2005年 | 19篇 |
2004年 | 24篇 |
2003年 | 21篇 |
2002年 | 15篇 |
2001年 | 22篇 |
2000年 | 10篇 |
1999年 | 16篇 |
1998年 | 8篇 |
1997年 | 12篇 |
1996年 | 11篇 |
1995年 | 6篇 |
1994年 | 5篇 |
1993年 | 1篇 |
1992年 | 2篇 |
1991年 | 4篇 |
1990年 | 7篇 |
1989年 | 9篇 |
1988年 | 6篇 |
1986年 | 2篇 |
排序方式: 共有513条查询结果,搜索用时 15 毫秒
1.
2.
Tanis B. C.; Verburgh C. A.; Van't Wout J. W.; Van Der Pijl J. W. 《Nephrology, dialysis, transplantation》1995,10(7):1240-1243
Aspergillus peritonitis is a rare complication of continuousambulatory peritoneal dialysis. The case is described of a 68-year-oldman in whom Aspergillus fumigatus was isolated from the peritonealdialysate after recurrent peritonitis with Gram-negative rodsin association with diverticulosis. Treatment consisting ofremoval of the catheter and intravenous administration of amphotericinB followed by oral itraconazole was successful. A review of the sparse literature (12 cases) displays uncertaintiesregarding diagnostic awareness, culture diagnosis, and therapeuticmanagement. Next to institution of appropriate antifungal therapy,early removal the peritoneal dialysis catheter is recommended,as delayed removal of the catheter appears to be associatedwith increased mortality and morbidity. 相似文献
3.
4.
5.
口服伊曲康唑与外用酮康唑洗剂联合治疗糠秕孢子菌性毛囊炎 总被引:2,自引:2,他引:2
王晖 《中国新药与临床杂志》2005,24(8):647-648
目的:观察口服伊曲康唑与外用酮康唑洗剂联合治疗糠秕孢子菌性毛囊炎的疗效。方法:选择临床症状典型,经真菌学检查确诊的糠秕孢子菌性毛囊炎病人52例,分为2组。治疗组27例中男性18例,女性9例,年龄(28±s11)a,与餐同服或餐后即服伊曲康唑200mg,qd,连续7d,同时外用2%酮康唑洗剂,qd,连续用药4wk。对照组25例中男性19例,女性6例,年龄(29±10)a,单纯口服伊曲康唑200mg,qd,疗程同上。观察用药后1,4wk,2组疗效。结果:对照组1,4wk有效率分别为52%和68%,治疗组分别为59%和96%,2组1wk疗效差异无显著意义,4wk疗效治疗组优于对照组。结论:口服伊曲康唑与外用酮康唑洗剂治疗糠秕孢子菌性毛囊炎疗效好。 相似文献
6.
Xue-Feng Lu Jian Zhan Yang Zhou Kai-Shun Bi 《Xenobiotica; the fate of foreign compounds in biological systems》2017,47(9):752-762
1.?The aim of this study was to investigate the influence of itraconazole (ITCZ) on tacrolimus absorption, distribution and metabolism by developing a semi-physiological pharmacokinetic model of tacrolimus in mice.2.?Mice were randomly divided into four groups, namely control group (CG, taking 3?mg kg?1 tacrolimus only), low-dose group (LDG, taking tacrolimus with 12.5?mg kg?1 ITCZ), medium-dose group (MDG, taking tacrolimus with 25?mg kg?1 ITCZ) and high-dose group (HDG, taking tacrolimus with 50?mg kg?1 ITCZ).3.?Liver clearance (CLli) decreased significantly (**p?<?0.01) in LDG (35.3%), MDG (45.2%) and HDG (58.7%) mice compared to CG mice. With respect to gut clearance (CLgu), significant (**p?<?0.01) decrease was also revealed in LDG (35.9%), MDG (50.2%) and HDG (64.6%) mice. A significant (**p?<?0.01) higher tacrolimus brain-to-blood partition coefficient (Kt,br) was found in MDG (25.3%) and HDG (55.9%) mice than in CG mice. Moreover, a significant (*p?<?0.05) increase (16.3%) was found in the absorption rate constant (Ka) in HDG mice compared to CG mice. There was a significant (**p?<?0.01) association between ITCZ dose and the change in CLgu (ΔCLgu, r=??0.790), the change in CLli (ΔCLli, r=??0.787) and the change in Kt,br (ΔKt,br, r?=?0.727), while the association between ITCZ dose and the change in Ka (ΔKa) was not significant (p?>?0.05).4.?These findings could be useful in predicting the efficacy and toxicity of tacrolimus, and drug–drug interaction of ITCZ and tarcolimus in human. 相似文献
7.
8.
Epidemiology of invasive fungal infections in lung transplant recipients on long‐term azole antifungal prophylaxis 下载免费PDF全文
Pearlie P. Chong Cassie C. Kennedy Matthew A. Hathcock Walter K. Kremers Raymund R. Razonable 《Clinical transplantation》2015,29(4):311-318
Lung transplant recipients (LTR) at our institution receive prolonged and mostly lifelong azole antifungal (AF) prophylaxis. The impact of this prophylactic strategy on the epidemiology and outcome of invasive fungal infections (IFI) is unknown. This was a single‐center, retrospective cohort study. We reviewed the medical records of all adult LTR from January 2002 to December 2011. Overall, 16.5% (15 of 91) of patients who underwent lung transplantation during this time period developed IFI. Nineteen IFI episodes were identified (eight proven, 11 probable), 89% (17 of 19) of which developed during AF prophylaxis. LTR with idiopathic pulmonary fibrosis were more likely to develop IFI (HR: 4.29; 95% CI: 1.15–15.91; p = 0.03). A higher hazard of mortality was observed among those who developed IFI, although this was not statistically significant (hazard ratio [HR]: 1.71; 95% confidence interval [CI] [0.58–4.05]; p = 0.27). Aspergillus fumigatus was the most common cause of IFI (45%), with pulmonary parenchyma being the most common site of infection. None of our patients developed disseminated invasive aspergillosis, cryptococcal or endemic fungal infections. IFI continue to occur in LTR, and the eradication of IFI appears to be challenging even with prolonged prophylaxis. Azole resistance is uncommon despite prolonged AF exposure. 相似文献
9.
10.
Timothy Pas Bjorn Vergauwen Guy Van den Mooter 《International journal of pharmaceutics》2018,535(1-2):47-58
Biopolymers have rarely been used so far as carriers in the formulation of amorphous solid dispersions (ASD) to overcome poor solubility of active pharmaceutical ingredients (APIs). In an attempt to enlarge our knowledge on this topic, gelatin, type 50PS was selected. A screening study was initiated in which twelve structurally different poorly soluble biopharmaceutical classification system (BCS) Class II drugs (carbamazepine, cinnarizine, diazepam, itraconazole, nifedipine, indomethacin, darunavir (ethanolate), ritonavir, fenofibrate, griseofulvin, ketoconazole and naproxen) were selected for evaluation. Solid dispersions of five different drug loadings of these twelve compounds were prepared by lyophilization and evaluated for their solid state properties by mDSC and XR(P)D, and in vitro dissolution performance. Even without any process optimization it was possible to form either fully amorphous or partially amorphous systems, depending on the API and API to carrier ratio. Hence in this respect, gelatin 50PS behaves as any other carrier. Dissolution of the API from the solid dispersions significantly exceeded that of their crystalline counterparts. This study shows the potential of gelatin as a carrier to formulate amorphous solid dispersions. 相似文献